Earnings Call · Q2 FY2026·2026-08-06

Q2 26EPS 0.00%·Rev n/aQ1 26EPS 0.00%·Rev n/aQ4 25EPS -1.85%·Rev n/aQ3 25EPS -11.11%·Rev n/a⚠ consensus missing

GoodRx Holdings, Inc. GDRX

Aubrey Reynolds — Director of Investor Relations

Wendy Barnes — Chief Executive Officer

Justin Fengler — Chief Financial Officer

+13.8%1d on move date3d+11.9%5d+9.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GDRX calls or request research access.

More GDRX calls Browse calls Request research access